MX2008011602A - Genes inducidos in vivo de mycobacterium tuberculosis. - Google Patents

Genes inducidos in vivo de mycobacterium tuberculosis.

Info

Publication number
MX2008011602A
MX2008011602A MX2008011602A MX2008011602A MX2008011602A MX 2008011602 A MX2008011602 A MX 2008011602A MX 2008011602 A MX2008011602 A MX 2008011602A MX 2008011602 A MX2008011602 A MX 2008011602A MX 2008011602 A MX2008011602 A MX 2008011602A
Authority
MX
Mexico
Prior art keywords
mycobacterium tuberculosis
induced genes
vivo induced
vivo
genes
Prior art date
Application number
MX2008011602A
Other languages
English (en)
Inventor
Jeffrey D Hillman
Original Assignee
Oragenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oragenics Inc filed Critical Oragenics Inc
Publication of MX2008011602A publication Critical patent/MX2008011602A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención proporciona composiciones y métodos para la detección de la Mycobacterium tuberculosis.
MX2008011602A 2006-03-13 2007-03-13 Genes inducidos in vivo de mycobacterium tuberculosis. MX2008011602A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78195306P 2006-03-13 2006-03-13
PCT/US2007/063858 WO2007106800A2 (en) 2006-03-13 2007-03-13 In vivo induced genes of mycobacterium tuberculosis

Publications (1)

Publication Number Publication Date
MX2008011602A true MX2008011602A (es) 2008-09-22

Family

ID=38510223

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008011602A MX2008011602A (es) 2006-03-13 2007-03-13 Genes inducidos in vivo de mycobacterium tuberculosis.

Country Status (9)

Country Link
US (1) US20100008922A1 (es)
EP (1) EP1999471A2 (es)
JP (1) JP2009530620A (es)
CN (1) CN101438165A (es)
AU (1) AU2007226658B2 (es)
CA (1) CA2646495A1 (es)
MX (1) MX2008011602A (es)
WO (1) WO2007106800A2 (es)
ZA (1) ZA200807255B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10197560B2 (en) 2013-06-27 2019-02-05 The Brigham And Women's Hospital, Inc. Methods and systems for determining M. tuberculosis infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458366B1 (en) * 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
WO1997026007A1 (en) * 1996-01-17 1997-07-24 Trustees Of Boston University Mycobacterium antigens and methods for their detection
US6245331B1 (en) * 1997-01-02 2001-06-12 New York Univ. Medical Center Early detection of mycobacterial disease
AU2002302919A1 (en) * 2001-02-22 2002-10-03 Institut Pasteur Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses

Also Published As

Publication number Publication date
ZA200807255B (en) 2009-08-26
CA2646495A1 (en) 2007-09-20
EP1999471A2 (en) 2008-12-10
CN101438165A (zh) 2009-05-20
AU2007226658A1 (en) 2007-09-20
WO2007106800A2 (en) 2007-09-20
WO2007106800A3 (en) 2008-03-27
AU2007226658B2 (en) 2011-10-27
US20100008922A1 (en) 2010-01-14
JP2009530620A (ja) 2009-08-27

Similar Documents

Publication Publication Date Title
IL250678A0 (en) Compounds and methods for repressing pcsk9 gene expression
WO2007081740A3 (en) Micrornarna-based methods and compositions for the diagnosis and treatment of solid cancers
PH12013502230A1 (en) Multispecific antibodies
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
IL192641A0 (en) Silicon based anticorrosive agent and methods using the same
MX2009003938A (es) Anticuerpos e inmunoconjugados y sus usos.
MY148635A (en) Anti-tat226 antibodies and immunoconjugates
EP2010659A4 (en) KITS AND METHOD FOR GENERATING RNA AT 5'-CAP STRUCTURE
MY197840A (en) Cross-linkers and their uses
MX337838B (es) Secuencias de repetidos palindromicos cortos regularmente intercalados agrupados de bifidobacterias.
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
MX2011012599A (es) Compuestos polimericos de agentes inmunomoduladores.
EP2032156A4 (en) COMPOSITIONS AND METHOD FOR THE DELIVERY OF OXYGEN
MX2010006576A (es) Composiciones y metodos para producir isopreno.
EP2007307A4 (en) PROCEDURE AND KITS FOR IDENTIFYING CARIES IN EARLY DAY
AP2011005671A0 (en) Herbicide-resistant AHAS-mutants and methods of use.
EP2023874A4 (en) METHOD FOR IDENTIFYING ACTIVE SUBSTANCES AND THEIR USE FOR THE PREVENTION OF RESTENOSIS
HK1129240A1 (en) Dna recombination junction detection
MX2009010783A (es) Deteccion de anaplasma platys.
EP2097523A4 (en) COMPOSITIONS AND METHODS OF USE OF CLIVE POLYMERASES
MX2010004566A (es) Prueba de deteccion de bordetella.
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
HK1142608A1 (en) 5-pyridinone substituted indazoles and pharmaceutical compositions thereof 5-
IL196861A0 (en) Antibodies against ccr5 and uses thereof
PH12013502194A1 (en) Antibodies to egfl7 and methods for their use

Legal Events

Date Code Title Description
FA Abandonment or withdrawal